Small Lymphocytic Lymphoma
📧 Sign up to get email alerts when something new happens for Small Lymphocytic Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: A Study to Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological Malignancies [Phase 1, Phase 2]
Update on the completed Phase 1/2 study of ZX-101A assessing activity, safety, and tolerability in relapsed/refractory hematological maligna…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL [Phase 2]
Phase 2 study evaluating idelalisib plus ofatumumab in previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma; the…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial evaluating acalabrutinib in combination with high-frequency, low-dose subcutaneous rituximab in previously untreated chronic l…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) [Phase 2]
Phase 2 trial update showing results for ofatumumab in high-risk chronic lymphocytic leukemia and small lymphocytic lymphoma, with trial res…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: 1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating Zydelig (idelalisib) as maintenance therapy after autologous stem cell transplantation in B-cell non-Hodgkin lympho…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 3]
Open-label extension Phase 3 study in patients aged 65 and older with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma; results po…
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating the effect of Vitamin D on progression-free survival in indolent non-Hodgkin lymphoma has completed with results po…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas [Phase 1, Phase 2]
First-in-human study of GEN3009 in relapsed or refractory B-cell non-Hodgkin lymphomas was terminated, with results posted thereafter.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating intermittent dosing of duvelisib in patients with chronic lymphocytic leukemia or small lymphocytic…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A terminated clinical trial update investigates immune responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia or sma…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 study assessing TG-1801 alone or with ublituximab in patients with CLL, SLL, and other B-cell lymphomas was terminated.
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 1]
Phase 1 safety and preliminary efficacy study of CC-99282 in combination with obinutuzumab in patients with relapsed or refractory chronic l…
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL [Phase 1, Phase 2]
Mustang Bio's MB-106 study in relapsed or refractory B-cell lymphomas and chronic lymphocytic leukemia has been terminated, covering Phase 1…
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.
A long-term follow-up update on patients previously treated with Mustang Bio's CAR-T cell investigational product; the trial has been termin…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: A Study of MS-553 in Patients With Relapsed or Refractory B-cell Lymphoma [Phase 1, Phase 2]
MS-553 trial in relapsed/refractory B-cell lymphomas was terminated after Phase 1/2 studies.
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib [Phase 1]
A Phase 1 clinical trial evaluating the combination of venetoclax with high-dose ibrutinib in chronic lymphocytic leukemia and small lymphoc…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: A Phase Ib Study of YY-20394 in Participants With B-cell Hematologic Malignancies [Phase 1]
Phase Ib study of YY-20394 in participants with B-cell hematologic malignancies has completed, evaluating safety and preliminary activity ac…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia [Phase 2]
A phase 2 trial evaluating acalabrutinib for relapsed or refractory autoimmune hemolytic anemia in patients with chronic lymphocytic leukemi…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: A Global Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL. [Phase 3]
A Phase 3 global trial evaluating Lisaftoclax (APG-2575) in combination with acalabrutinib versus immunochemotherapy for newly diagnosed chr…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Biological and Clinical Efficacy of Shingrix in Patients With CLL [NA]
Registry entry describing a trial to assess the biological and clinical efficacy of Shingrix in patients with chronic lymphocytic leukemia a…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma [Phase 1]
A Phase 1 study evaluating the safety and preliminary efficacy of the combination of duvelisib and nivolumab in patients with Richter syndro…
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial investigating curcumin and cholecalciferol in previously untreated stage 0-II chronic lymphocytic leukemia or small lymphocyti…
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: Nivolumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or High-Risk Untreated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Richter Transformation [Phase 2]
Phase 2 trial evaluating nivolumab and ibrutinib in relapsed/refractory or high-risk untreated chronic lymphocytic leukemia, small lymphocyt…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL [Phase 3]
Phase 3 trial comparing Zanubrutinib with Bendamustine plus Rituximab in previously untreated chronic lymphocytic leukemia or small lymphocy…
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: A Study of Orelabrutinib in CLL/SLL Patients Who Are Slowly Responding to Ibrutinib [Phase 2]
Phase 2 trial assessing orelabrutinib in CLL/SLL patients with slow response to ibrutinib is ongoing; current status is unknown.